MDCO

Medicines Co

MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

220 hedge funds and large institutions have $4.52B invested in Medicines Co in 2017 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 87 increasing their positions, 62 reducing their positions, and 22 closing their positions.

2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3 2013 Q2

Holders

220

Holders Change

+25

Holders Change %

+12.82%

% of All Funds

5.48%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

+75%

% of All Funds

0.35%

New

Increased

Reduced

Closed

Calls

$101M

Puts

$77.5M

Net Calls

+$23.7M

Net Calls Change

+$23.8M

Top Buyers

1	1 BlackRock New York	$475M
2	AH 2 Aviva Holdings New Providence, Bahamas	$187M
3	IAM 3 Iridian Asset Management Westport, Connecticut	$148M
4	4 Goldman Sachs New York	$101M
5	TBC 5 Three Bays Capital Boston, Massachusetts	$66.7M

Top Sellers

1	PHS 1 PFM Health Sciences San Francisco, California	$90.5M
2	2 Wells Fargo San Francisco, California	$4.05M
3	TCM 3 Tekla Capital Management Boston, Massachusetts	$0
4	4 UBS AM Chicago, Illinois	$52.9M
5	5 Invesco Atlanta, Georgia	$47.9M

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	1 Fidelity Investments Boston, Massachusetts	$524M	10,707,056	+87,958	+0.8%
2	2 Wellington Management Group Boston, Massachusetts	$488M	9,981,861	+79,001	+0.8%
3	3 BlackRock New York	$475M	9,704,494	+9,697,317	+135,117%
4	4 Vanguard Group Malvern, Pennsylvania	$298M	6,090,730	+313,876	+5%
5	AH 5 Aviva Holdings New Providence, Bahamas	$187M	3,833,999	+3,833,999	New
6	CM 6 Corvex Management New York	$159M	3,252,260	+20,000	+0.6%
7	IAM 7 Iridian Asset Management Westport, Connecticut	$148M	3,022,681	+2,074,261	+219%
8	8 Goldman Sachs New York	$101M	2,070,279	+1,364,302	+193%
9	9 State Street Boston, Massachusetts	$99.6M	2,037,113	-18,315	-0.9%
10	PHS 10 PFM Health Sciences San Francisco, California	$90.5M	1,850,635	-866,806	-32%
11	BM 11 Bridger Management New York	$88.9M	1,818,488	+193,974	+12%
12	SCM 12 Sarissa Capital Management Greenwich, Connecticut	$85.7M	1,752,000	–	–
13	13 Dimensional Fund Advisors Austin, Texas	$70.5M	1,442,658	-27,845	-2%
14	14 Franklin Resources San Mateo, California	$69.5M	1,422,009	-1,195	-0.1%
15	15 T. Rowe Price Associates Baltimore, Maryland	$68M	1,390,146	-58,310	-4%
16	TBC 16 Three Bays Capital Boston, Massachusetts	$66.7M	1,363,529	+1,363,529	New
17	PA 17 Pinnacle Associates New York	$64.5M	1,318,106	-60,186	-4%
18	BC 18 Boxer Capital San Diego, California	$59.4M	1,215,000	+386,802	+47%
19	19 AllianceBernstein Nashville, Tennessee	$58.4M	1,194,625	-76,015	-6%
20	ACA 20 Avoro Capital Advisors New York	$57.9M	1,185,000	+1,185,000	New
21	BRC 21 Blue Ridge Capital New York	$53.8M	1,100,000	+1,100,000	New
22	PC 22 PointState Capital New York	$53.6M	1,095,100	+1,095,100	New
23	23 UBS AM Chicago, Illinois	$52.9M	1,080,813	-468,424	-30%
24	24 First Eagle Investment Management New York	$48.5M	990,899	-64,130	-6%
25	25 Invesco Atlanta, Georgia	$47.9M	979,202	-439,902	-31%

Medicines Co MDCO

Top Buyers

Top Sellers

Medicines Co

MDCO